Objectives: Ischemia-reperfusion acute lung injury is characterized by increased vascular permeability, lung edema, and neutrophil sequestration. Ischemia-reperfusion acute lung injury occurs in lung transplantation and other major surgical procedures. Effective regulation of alveolar fluid balance is critical for pulmonary edema. Sodium-potassium-chloride co-transporter regulates alveolar fluid and is associated with inflammation. We hypothesized that sodium-potassium-chloride co-transporter is important in ischemia-reperfusion acute lung injury. Bumetanide, a sodium-potassium-chloride co-transporter inhibitor, is used to treat pulmonary edema clinically. We studied the effect of bumetanide in ischemiareperfusion acute lung injury.
Results: In wild-type mice, ischemia-reperfusion caused lung edema (wet/dry weight 6.30 AE 0.36) and hyperpermeability (microvascular permeability, 0.29 AE 0.04), neutrophil sequestration (255.0 AE 55.8 cells/high-power field), increased proinflammatory cytokines, and nuclear factor-kB activation (1.33 AE 0.13). Acute lung injury was more severe in WNK4 mice with more lung edema, permeability, neutrophil sequestration, and nuclear factor-kB activation. Severity of acute lung injury was attenuated in SPAK À/À mice. Bumetanide decreased pulmonary edema (wild-type: wet/dry weight 5.05 AE 0.44, WNK4: wet/dry weight 5.13 AE 0.70), neutrophil sequestration (wild-type: 151.7 AE 27.8 cells/high-power field, WNK4: 135.3 AE 19.1 cells/high-power field), permeability (wild-type: 0.19 AE 0.01, WNK4: 0.21 AE 0.03), cytokines, and nuclear factor-kB activation after ischemia-reperfusion.
Higher NKCC1 leads to severe lung injury with higher edema, permeability, and inflammation.
Central Message
Higher NKCC1 leads to more severe ALI with greater lung edema, permeability, and neutrophil sequestration. Manipulations that decrease NKCC1 can attenuate the severity of lung injury.
Perspective NKCC1 regulates ion transport and fluid balance in the lungs. NKCC1 may play a critical role in ALI. However, the study on the role of NKCC1 in IR-induced ALI is lacking. Our study found that NKCC1 plays an important role in IR-induced ALI. Genetic and pharmacologic manipulation to decrease NKCC1 can attenuate ALI by suppressing the NF-kB pathway.
See Editorial Commentary page 216. Acute lung injury (ALI) induced by ischemia-reperfusion (IR) occurs when the lungs are exposed to periods of IR. 1 ALI is characterized by increased pulmonary vascular permeability, lung edema, neutrophil sequestration, and hypoxemia. 1 IR-induced ALI occurs in many clinical situations, including lung transplantation, cardiopulmonary bypass, and other major surgical procedures. 2, 3 Lung transplantation provides a curative therapy for patients with end-stage lung diseases. However, the shortage of donor organs remains a major limiting factor in the widespread application of lung transplantation. 4 Despite advances in organ preservation and perioperative care, IRinduced ALI remains a significant cause of mortality and morbidity after lung transplantation. 4 Therefore, there is an increasing effort to study IR-induced ALI to improve outcomes in lung transplantation. 5, 6 Alveolar fluid regulation is considered to have a critical role in the development of pulmonary edema in lung injury. Ion channels in the lung epithelium regulate water influx and efflux and are likely to be important in IR-induced ALI. However, previous studies on the role of ion channels in IR-induced ALI have been inconclusive, and the role of ion channels in ALI is still not fully understood. To gain a better understanding of the role of fluid regulation in lung injury, studies that address the underlying mechanisms and the involvement of ion channels will be important. This may lead to new therapeutic options for the management of ALI.
The sodium-potassium-chloride co-transporter (NKCC) regulates intracellular volume by coupling the transport of sodium (Na þ ), chloride (Cl À ), and potassium (K þ ). 7 Two isoforms of the NKCC have been identified: NKCC1 and NKCC2. Only NKCC1 is expressed in alveolar epithelial cells, whereas NKCC2 expression is restricted to the kidney.
7 NKCC1 is located basolaterally in the lung epithelium that mediates a net influx of ions into cells. 8 Therefore, the chemical gradient that creates the driving force for water transport is mediated primarily by NKCC1. 8 The activity of epithelial NKCC1 is regulated by a phosphorylation signaling cascade consisting of with-nolysine kinase (WNK), oxidative stress responsive kinase-1 (OSR1), and STE20/SPS1-related proline/alanine rich kinase (SPAK). 9 SPAK and OSR1 are downstream substrates of WNK1 and WNK4 kinases and upstream regulators of NKCC1. 9 Activation of WNK4 has been shown to activate the OSR1/SPAK phosphorylation cascade. 9 Phosphorylated OSR1 and SPAK are known to phosphorylate NKCC1. 9 Although it is well documented that the WNK-SPAK pathway plays a crucial role in systemic salt and water homoeostasis, 9 its role in regulating pulmonary fluid clearance is largely unknown. Nuclear factor-kappaB (NF-kB) and proinflammatory cytokines, including interleukin-6, macrophage chemoattractant protein-1, and tumor necrosis factor-a (TNF-a), play important roles in lung injury. 10 A study exploring the central role for NF-kB in the induction of lung injury revealed that NF-kB is a critical regulator of the inflammatory response in lung injury, with inhibition of NF-kB activation, reduction of IR injury, and improvement of pulmonary graft function.
11 NF-kB also plays a critical role in SPAK regulation. 10 During IR, the NF-kB pathway is activated and regulates not only proinflammatory cytokines but also SPAK and NKCC1 activity. 10 Thus, we hypothesized that the pathogenic mechanisms underlying ALI involve an interplay among NKCC1, NF-kB, and proinflammatory cytokines. Because NKCC1 is important in fluid and inflammation regulation, we hypothesized that NKCC1 should be important in IR-induced ALI. WNK4 D561A/þ knockin mice are identified as having increased expression of NKCC1 through the activation of the OSR1/SPAK-NKCC1 phosphorylation cascade. 12 SPAK À/À mice, in contrast, are identified as having very low NKCC1 function. 13 In addition, bumetanide is a known drug to inhibit NKCC1.
14 Bumetanide is a potent loop diuretic that produces a rapid and marked diuresis.
14 Its principal site of action is the loop of Henle in kidney.
14 For NKCC1 present in lung tissues, 7 bumetanide should have an effect in lung injury. The aim of the present study was to determine the role of NKCC1 in IR-induced ALI via genetic and pharmacologic manipulations.
MATERIALS AND METHODS Animals
, and wild-type (WT) mice were used in this study. SPAK À/À and WNK4 D561A/þ mice were generated as described previously. 12, 15 Male mice aged 10 to 12 weeks were used in this study. The National Science Council and Animal Review Committee of the National Defense Medical Center (Taipei, Taiwan) approved the study protocol. The animals were cared for in accordance with the ''Guide for the Care and Use of Laboratory Animals,'' published by the US National Institutes of Health.
Isolation and Perfusion of Lungs
The video and schematic diagram indicating the experimental procedure for isolation and perfusion of lungs are shown in Video 1 and Figure 1 . Procedures regarding the preparation of isolated-perfused lungs in situ were performed as previously described. 16 Mice were anesthetized through intraperitoneal injection of Zoletil (20 mg/kg; Virbac, Carros, France).
After confirmation of deep anesthesia, tracheostomy was performed and a cannula (Becton Dickinson, Franklin Lakes, NJ) was inserted into the trachea. After tracheostomy, mice were ventilated with a gas mixture containing 2.5% CO 2 in 97.5% air using a rodent ventilator. Respiratory rate was maintained at 90 breaths/min, tidal volume was maintained at 0.5 mL, and end-expiratory pressure was maintained at 1 cm H 2 O. The chest was opened by median sternotomy, and heparin (500 U) was injected into the right ventricle to prevent blood coagulation; 1 mL of intracardiac blood was withdrawn. After a right ventriculotomy, a catheter was inserted into the main pulmonary artery (PA), and the PA and ascending aorta were tied together using a silk suture. Pulmonary artery pressure (PAP) was measured using a pressure sensor, which was connected to the PA catheter. The other end of the catheter was connected to a tube for pulmonary perfusion. After a small incision of the left ventricle, the catheter was inserted into the left atrium via a left ventriculotomy, and the catheter was used to collect the effluent perfusate for recirculation. The pulmonary circulation was maintained in a closed circuit via a peristaltic pump (Model 1203, Harvard Apparatus). The peristaltic pump (Gilson Inc, Villiers le Bel, France) was used to perfuse the lungs with recirculated perfusate. The perfusate consisted of 1 mL blood mixed with 9 mL physiologic salt solution (119 mmol/L NaCl, 4.7 mmol/L KCl, 1.17 mmol/L MgSO 4 , 22.6 mmol/L NaHCO 3 , 1.18 mmol/L KH 2 PO 4 , 1.6 mmol/L CaCl 2 , 5.5 mmol/L glucose, and 50 mmol/L sucrose). Bovine albumin (4 g/dL) was added to maintain the osmolarity of the perfusate. The perfusion rate was maintained at 1 mL/min using a roller pump and kept at constant temperature (37 C) using a water bath. FIGURE 1. Isolated lung model. After confirmation of deep anesthesia, tracheostomy was performed and a cannula was inserted into the trachea. Mice were ventilated with a gas mixture containing 2.5% CO 2 in 97.5% air via a rodent ventilator. The chest was opened by median sternotomy, and heparin (500 U) was injected into the right ventricle to prevent blood coagulation. After a right ventriculotomy, a catheter was inserted into the main PA, and the PA and ascending aorta were tied together using a silk suture. PAP was measured using a pressure sensor, which was connected to the PA catheter. The other end of the catheter was connected to a tube for pulmonary perfusion. After a small incision of the left ventricle, the catheter was inserted into the left atrium via a left ventriculotomy. This catheter was placed in the left atrium to collect the effiuent perfusate for recirculation. The pulmonary circulation was maintained in a closed circuit via a peristaltic pump. PAP, Pulmonary artery pressure; PVP, pulmonary venous pressure. VIDEO 1. Isolated perfusion of lungs in situ was performed. After deep anesthesia, tracheostomy was performed and a cannula was inserted into the trachea. The mice were ventilated via a rodent ventilator. The chest was opened by median sternotomy, and 1 mL of intracardiac blood was withdrawn. A catheter was inserted into the main PA after performing a right ventriculotomy. The other end of the catheter was connected to a tube for pulmonary perfusion. After a small incision of the left ventricle, the catheter was inserted into the left atrium via a left ventriculotomy. This catheter was placed in the left atrium to collect the effluent perfusate for recirculation. The pulmonary circulation was maintained in a closed circuit via a peristaltic pump. During the experiment, LW and Kf were measured at baseline and post-IR. PAP was measured using a pressure sensor, which was connected to the pulmonary arterial catheter. Video available at: http://www.jtcvsonline.org/article/S0022-5223 (16) The IR-induced ALI was performed with 120 minutes of ischemia by stopping ventilation and perfusion of deflated lung. The lungs were then reperfused and ventilated for 60 minutes. During the procedure, measurements of lung weight (LW) and microvascular permeability (Kf) were taken at baseline and post-IR. In the control group, IR was not performed and the second measurements were taken after 180 minutes at the same time as in the IR group. We continuously monitored PAP and left atrial pressures, which represent the pulmonary venous pressure (PVP). We recorded the PAP before IR injury as baseline PAP. Changes of PAP during IR were calculated for each time point by subtracting baseline PAP.
The hilum of the right lungs was ligated, and the right upper and lower lobes were removed for immunoblotting. The right middle lobe was excised for analysis of wet/dry weight ratio (W/D). The remaining left lung was lavaged twice with 0.5 mL phosphate-buffered saline (PBS), and the bronchoalveolar lavage fluid (BALF) was centrifuged at 200g for 10 minutes. Concentrations of total protein, TNF-a, and macrophage inflammatory protein-2 (MIP-2) in BALF were measured. Histopathologic examination was processed on the right lung in a separate procedure.
Microvascular Permeability
An index of Kf is determined from the LW change induced by elevated PVP. 17 During ventilation and perfusion, the PVP was rapidly elevated by 10 cm H 2 O for 7 minutes. The slow, steady phase of weight gain as a function of time (DW/DT) was plotted on a semilogarithmic paper and then extrapolated to zero time to obtain the initial rate of transcapillary filtration. From this plot, Kf was defined as the y-intercept (g/min) divided by PVP and LW, and expressed in whole units of grams per minute per centimeter of H 2 O multiplied by 100g. 17 
Total Protein Concentration and Cytokine Levels in Bronchoalveolar Lavage Fluid
Total protein concentration in the supernatant was determined using the bicinchoninic acid protein assay (Pierce, Rockford, Ill). Concentrations of TNF-a and MIP-2 levels were determined using a commercially available enzyme-linked immunosorbent assay (R&D Systems Inc, Minneapolis, Minn).
Pulmonary Edema
The right middle lobe was removed, and the wet weight was determined. The lung was then dried in an oven at 60 C for 48 hours. The wet and dry weights were measured to calculate the lung W/D.
Lung Histopathology
The tissues were immersed in 10% formaldehyde fixative for 24 hours and then embedded in paraffin wax and cut into 2 mm-thick sections using a microtome. The sections were stained with hematoxylin-eosin to assess the interstitial edema and the degree of neutrophil sequestration. The number of neutrophils in the interstitium and alveoli was determined as the average number of neutrophils per high-power field (4003). A minimum of 10 fields were randomly examined by an observer blinded to the study. 18 Lung injury also was scored according to (1) infiltration or aggregation of neutrophils in the airspace or vessel wall and (2) thickness of the alveolar wall. Each assessment was graded 0, 1, 2, or 3 corresponding to no, mild, moderate, or severe injury, respectively. 19 Immunoblotting Cytoplasmic and nuclear proteins were extracted from frozen lung tissues with the Nuclear/Cytosol Extraction kit (BioVision, Inc, Mountain View, Calif) according to the manufacturer's instructions. Protein concentrations were determined using the bicinchoninic acid protein assay, and equal amounts of lung homogenates (30 mg/lane) were fractionated on 10% to 12% sodium dodecyl sulfate-polyacryl-amide gel electrophoresis gels and transferred to Hybond polyvinylidene fluoride membranes (Millipore, Schwalbach, Germany). The membranes were blocked by incubation in PBS containing 0.1% Tween 20 and 5% nonfat milk for 1 hour at room temperature. Blots were incubated with antibodies to NKCC1, phosphorylated-NF-kB p65, inhibitor of NF-kB (IkB)-a, phosphorylated IkB kinase (IKK)-b, and total IKK (Cell Signaling Technology, Danvers, Mass) overnight at 4 C. The blots were then washed 3 times for 10 minutes in PBS containing 0.1% Tween 20. The blots were incubated with horseradish peroxidase linked anti-rabbit immunoglobulin G (1:40,000) or antigoat immunoglobulin G (1:50,000) for 1 hour at room temperature and then washed 3 times in PBS containing 0.1% Tween 20 for 10 minutes. Bands were visualized using enhanced chemiluminescence reagents and exposure to radiography film. The blots were then stripped and incubated with an anti-TATA antibody (for nuclear protein, diluted 1:1000; Abcam, Cambridge, Mass) or anti-b-actin antibody (for cytoplasmic protein, diluted 1:10,000; Sigma, St Louis, Mo) to ensure equal loading.
Data Analysis
All statistical analyses were performed using SPSS version 18.0 (SPSS Inc, Chicago, Ill). All of the values are reported as means AE standard deviation. Differences between groups were evaluated using the KruskalWallis test followed by post hoc comparisons with Games Howell tests (for intergroup comparison). The generalized estimating equation method was used to examine changes in PAP during the reperfusion period across the times in different groups.
RESULTS

Changes of Pulmonary Artery Pressure After Ischemia-Reperfusion
Changes of PAP are shown in Figure 2 . In the control group, PAP did not significantly change throughout the 60-minute observation period. After IR, PAP showed a bimodal change during the 60-minute reperfusion period. An initial rapid increase in the perfusion pressure was followed by a steady phase of gradual increase. Changes of PAP were greater in WNK4 D561A/þ knockin and WT mice and lower in SPAK À/À mice after IR (P < .05 compared with the WT-IR group). In SPAK À/À mice, changes of PAP after IR were similar to the control group. In the IR þ bumetanide group (IR-B), bumetanide abolished the PAP elevation in WNK4 D561A/þ knockin and WT mice (P <.05 compared with IR). Changes of PAP were less in SPAK À/À or bumetanide-treated mice, which had lower NKCC1 function.
Changes of Lung Weight After Ischemia-Reperfusion
The LW/body weight (LW/BW) and W/D are shown in Figure 3 . The lung LW/BW was similar across control groups (P >.05) (Figure 3, A) . After IR, the LW/BW was D561A/þ -IR-B and WT-IR-B (both P < .05 compared with IR). Lung W/D was similar across the control groups (P > .05) (Figure 3, B) . After IR, lung W/D was significantly increased and higher in WNK4 D561A/þ knockin mice than in WT mice and SPAK À/À mice (P <.05 compared with WT-IR group). Lung W/D was decreased both in
WNK4
D561A/þ -IR-B and WT-IR-B (both P<.05 compared with IR). The pulmonary edema was less severe in SPAK À/À or bumetanide-treated mice, which had lower NKCC1 function.
Changes of Microvascular Permeability After Ischemia-Reperfusion
Kf was similar in the control groups (P>.05) (Figure 4 ). Kf was significantly increased compared with baseline after FIGURE 2. Changes of PAP after IR. In the control group, PAP did not change significantly throughout the 60-minute observation period. After IR, PAP showed a bimodal change during the 60-minute reperfusion period. An initial rapid increase in the perfusion pressure was followed by a steady phase of gradual increase. Changes of PAP were greater in WNK4 D561A/þ knockin and WT mice and lower in SPAK À/À mice after IR (P <.05 compared with the WT-IR group). In SPAK À/À mice, changes in PAP after IR were similar to those in the control group. In the IR þ bumetanide group, bumetanide abolished the PAP elevation in WNK4 D561A/þ knockin and WT mice (P <.05 compared with IR). *Significantly different from IR in each group (P <.05).
#Significantly different among WT-IR, WNK4-IR, and SPAK
À/À -IR (P <.05). A, WT, WT with IR (WT-IR), and WT-IR with bumetanide (WT-IR-B). B, WNK4
D561A/þ (WNK4), WNK4 , with-no-lysine kinase 4 knockin; SPAK, STE20/SPS1-related proline/alanine rich kinase knockout. IR in WT (P > .05) and WNK4 D561A/þ knockin mice (P <.05), but not in SPAK À/À mice (P >.05). IR-induced elevations in Kf were decreased with bumetanide treatment in both WNK4 D561A/þ knock-in and WT mice (P < .05 compared with IR). The microvascular hyperpermeability was less in SPAK À/À or bumetanide-treated mice, which had lower NKCC1 function.
Histopathologic Presentations After Ischemia-Reperfusion
Histopathologic examinations were performed to verify the microanatomic features of lung injury imposed by IR ( Figure 5 ) and to assess the influence of NKCC1 on neutrophil sequestration ( Figure 6 ). Control groups had normal histology ( Figure 5, A-C) . Post-IR histopathology of WT ( Figure 5, D) and WNK4 D561A/þ mice ( Figure 5, F) showed severe lung injury with pulmonary edema, alveolar wall thickening, and neutrophil sequestration. The degree of ALI was less severe in SPAK À/À mice ( Figure 5, H) . The features of ALI in WT and WNK4 D561A/þ mice were markedly attenuated by bumetanide (Figure 5 , E and G).
Neutrophil counts in the interstitium and alveoli were markedly increased in WNK4 D561A/þ and WT mice after IR (P < .05 compared with control groups) (Figure 6, A) . SPAK À/À mice showed less neutrophil sequestration in the lungs compared with the WT-IR group (P<.05). Bumetanide decreased IR-induced neutrophil sequestration in both WT and WNK4 D561A/þ mice (P <.05 compared with IR). ALI scores were similar across control groups (P > .05) (Figure 6, B) . After IR, ALI scores were markedly increased in WNK4 D561A/þ (P <.05 compared with control) and WT mice (P <.05 compared with control) and less in SPAK À/À mice (P>.05 compared with control). Bumetanide decreased ALI scores after IR in both WTand WNK4 D561A/þ mice (both P<.05 compared with IR). The severity of ALI and neutrophil sequestration was less in SPAK À/À or bumetanide-treated mice, which had lower NKCC1 function.
Concentrations of Total Protein and Proinflammatory Cytokines After Ischemia-Reperfusion
Total protein concentration in BALF, an indicator of vascular leakage, was significantly increased after IR (P<.05) (Figure 7, A) . Total protein concentration was higher in WNK4 D561A/þ mice and lower in SPAK À/À mice (P<.05). Bumetanide decreased IR-induced elevation of total protein concentration in WT and WNK4 D561A/þ mice (P < .05 compared with IR). MIP-2 and TNF-a levels were significantly higher after IR in WT (P <.05) and WNK4 D561A/þ mice (P <.05) (Figure 7 , B and C). SPAK À/À mice had less MIP-2 and TNF-a after IR (P <.05 compared with WT and WNK4 D561A/þ mice post-IR). Bumetanide attenuated IRinduced increases in MIP-2 (both P < .05 compared with IR) and TNF-a (both P<.05 compared with IR). The concentrations of total protein and proinflammatory cytokines were less in SPAK À/À or bumetanide-treated mice.
Nuclear Factor-kB Activation and Nuclear Translocation After Ischemia-Reperfusion NF-kB p65, IkB-a, and phosphorylated IKKb before and after IR are shown in Figure 8 . After IR, the cytoplasmic levels of phosphorylated IKKb and nuclear level of NFkB p65 were increased (P <.05). In contrast, IkB-a levels were significantly reduced in WT and WNK4 D561A/þ mice (P <.05). Changes in NF-kB p65, IkB-a, and phosphorylated IKKb levels were not observed in SPAK À/À mice. Bumetanide restored IkB-a levels and reduced phosphorylated IKKb and NF-kB p65 levels after IR in WT and WNK4 D561A/þ mice (P <.05 compared with IR). The NFkB activation was less in SPAK À/À or bumetanide-treated mice, which had lower NKCC1 function.
DISCUSSION
The findings of this study indicate that differences in expressions of NKCC1 influence the response to IR-induced THOR lung injury. Higher NKCC1 expression leads to more severe IR-induced ALI with increased pulmonary edema, higher Kf, elevations in inflammatory cytokine levels, and increased neutrophil sequestration. Manipulations that decrease NKCC1 expressions were found to reduce the severity of lung injury. This study indicates that the WNK4-SPAK-NKCC1 pathway is important in regulating alveolar homeostasis and inflammation in IR-induced ALI. Studies on the role of NKCC1 in IR-induced lung injury are lacking. It is suggested that NKCC1 regulates the lung endothelial and epithelial barriers, and modulates the inflammatory response to pneumonia and hyperoxiaassociated lung injury. [20] [21] [22] Fluid regulation is critical in the development of pulmonary edema. The NKCC1 works to transport Cl À and is involved in the regulation of epithelial cell volume. 23 Increased NKCC1 in lung injury results in cell swelling and retention of ions and fluid in the alveolar space resulting in aggravation of lung edema and injury. 20 Solymosi and colleagues 24 also identified NKCC1 as a Cl À entry channel with regulation of fluid transport. It is shown that the NKCC inhibitor, bumetanide, attenuates alveolar Cl À influx and blocks alveolar fluid secretion. 24 Therefore, NKCC1 influences both inflammatory responses and fluid regulation. Upregulating NKCC1 leads dysregulation of fluid transport and leads to cell swelling and inflammation. 25, 26 Cellular swelling results in apoptosis and membrane rupture. 27 Consequently, apoptotic cells further release inflammatory mediators and proinflammatory cytokines. 27 Therefore, higher NKCC1 expression in WNK4 D561A/þ mice lead to a decrease in the rate of alveolar liquid absorption and resulted in more severe pulmonary edema after IR. Conversely, lower NKCC1 expression in SPAK À/À mice showed resulted in less severe IR-induced lung injury.
The transcription factor NF-kB has a key role in SPAK regulation via an NF-kB binding site in the 5'-flanking region of the SPAK gene. 10 After IR the, NF-kB pathway is activated, which regulates proinflammatory cytokines and SPAK pathway. 10 SPAK is important in epithelial transport, cell volume regulation, and cell survival. 15 Activation of SPAK after IR may lead to aggravation of lung injury via 2 possible mechanisms: (1) As an upstream kinase, SPAK may phosphorylate and activate NKCC1, 28 resulting in cell swelling, injury, and lung edema due to increased NKCC1 and SPAK activity after IR; and (2) activation of the p38 mitogen activated protein kinase (MAPK) pathway via SPAK, which leads to inflammation. 15, 28 Activation of the p38 MAPK pathway has been shown to correlate with apoptosis. 29 Moreover, Wei and colleagues 30 found that activation of p38 MAPK led to upregulation of inflammatory responses in lung injury and promoted inflammatory cytokines production. WNK4-SPAK-NKCC1 pathway is associated with cellular swelling and susceptibility to lung edema and injury after IR, 25, 26 as well as inflammatory 
responses in lung injury. 30 Consistent with these findings, IR-induced ALI was attenuated in SPAK À/À mice or after administration of the NKCC1 inhibitor bumetanide in the present study.
Neutrophils play an essential role in the onset of ALI, 31 and activation of NF-kB pathway further increases neutrophil sequestration. 10 Migration of neutrophils into the air spaces could be explained by a chemotactic effect of higher After IR, ALI scores were markedly increased in WNK4 D561A/þ (P <.05 compared with control) and WT mice (P <.05 compared with control) and less in SPAK proinflammatory cytokine levels in mice with greater NKCC1 expression. Moreover, neutrophils can degranulate and release toxic intracellular products, free radicals, and cytotoxic enzymes that lead to lung injury. 17, 31 The chemotactic effect of proinflammatory cytokines leads to migration of neutrophils into lung tissue. In WNK4 D561A/þ mice with higher NKCC1 expression, levels of proinflammatory cytokines and neutrophil sequestration are enhanced after IR and lead to more severe ALI. In SPAK À/À mice with lower NKCC1 expression, the levels of proinflammatory cytokines and neutrophil sequestration are attenuated and the severity of lung injury after IR is reduced.
Bumetanide is a potent loop diuretic that produces a rapid and marked diuresis and is often used for the treatment of pulmonary edema clinically.
14 Pharmacologically, as a diuretic, bumetanide is approximately 40-fold more potent than furosemide. 14 In the clinical scenario, we cannot differentiate the effect of bumetanide through the kidney (as diuretics) or lung. By applying an isolatedperfused lung model, we can confirm that bumetanide clearly has an effect on the lung. NKCC1 regulates lung endothelial and epithelial barriers, and modulates the inflammatory response to lung injury. [20] [21] [22] In our study, bumetanide-treated mice showed less lung inflammation and edema after IR. Previous studies also showed that administration of bumetanide in ALI reduces intracellular Cl-concentration and fluid content, and further reduces cell swelling. 32, 33 The beneficial effects of bumetanide not only regulate fluid transportation but also decrease lung inflammation.
Clinical Implications
Lung transplantation provides the hope of a curative option for many patients with end-stage pulmonary disease. Unfortunately, the shortage of donor organs remains a major limiting factor in its widespread application of lung transplantation. 4 Despite advances in organ preservation, IR-induced ALI is one of the main causes of primary graft failure contributing to mortality after lung transplantation. 5, 6 Therefore, effective organ preservation is one of the key factors for successful lung transplantation. 4 Although modern preservation techniques have revolutionized transplantation surgery, many investigators are still working toward a more reliable preservation method. In the present study, we suggested that by inhibiting NKCC1, bumetanide can attenuate IR-induced lung edema and injury. This investigation provides an impetus to consider approaches that address the role of NKCC1 inhibitors in this clinical setting of lung transplantation. Akindipe and colleagues 34 also suggested the benefits of diuresis in lung transplant recipients with pulmonary edema. Therefore, we suggested the trial of bumetanide in the patients with lung injury or edema after lung transplantation.
Study Limitations
The present study has limitations in relation to the animal species and the isolated lung model used. However, by applying an isolated-perfused lung in situ, we can exclude the potential effects of NKCC1 in other organs. Thus, our data clearly highlight a role for NKCC1 in lung injury. However, further clinical studies on the roles of NKCC1 and the therapeutic effects of NKCC1 inhibition in IR-induced ALI FIGURE 8. NF-kB activation and nuclear translocation after IR. After IR, the nuclear levels of NF-kB p65 (A) and cytoplasmic levels of phosphorylated IKKb (B) were increased, whereas the IkB-a (C) levels were significantly suppressed in WT and WNK4 D561A/þ mice. Changes in NF-kB p65, IkB-a, and in humans are warranted. Although endothelial function is known to be important in ALI, 35 the relationship between epithelial NKCC1 and endothelial dysfunction remains unknown. Further studies are needed to determine the influence of NKCC1 on endothelial function.
CONCLUSIONS
IR-induced ALI presents with microvascular hyperpermeability, pulmonary edema, activation of NF-kB pathway, increased levels of proinflammatory cytokines, and neutrophil sequestration. The extent of NKCC1 expression in IR is associated with the level of activation of the NF-kB pathway, amount of neutrophilic infiltration, and severity of lung injury. Functional reduction of NKCC1 by gene knockout or pharmacologic treatment with bumetanide to inhibit NKCC1 resulted in a lower severity of IR-induced ALI. Therefore, we suggest that alterations in NKCC1 function influence various inflammatory responses to IR. NKCC1 may present a promising target for pharmacologic interventions in a clinical setting.
